InvestorsHub Logo
Followers 13
Posts 1091
Boards Moderated 0
Alias Born 07/19/2013

Re: None

Tuesday, 03/06/2018 10:07:09 AM

Tuesday, March 06, 2018 10:07:09 AM

Post# of 54
Biohaven Enrolls First Patient In Phase 3 Clinical Trial To Evaluate Rimegepant Zydis® ODT In The Acute Treatment Of Migrain...
https://ih.advfn.com/p.php?pid=nmona&article=76871413

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CTLT News